Medicine was an important part of medieval Islamic life; both rich and poor people were interested in health and diseases. Islamic doctors and a number of scholars wrote profusely on health and ...
Biofilm-associated infections are notoriously difficult to treat, and they also play a role in antibiotic resistance as more antimicrobials are urgently needed to treat biofilm-associated infections.
The apparent contradiction begins immediately, with the book’s title: “Healing with Poisons.” But in this sweeping examination of poison’s role in medieval Chinese medicine, Yan Liu, assistant ...
One of our current global threats is antibiotic resistance. As more biofilm-associated infections are becoming hard to treat, the burden on scientists to find solutions is increasing. Now, researchers ...
Medieval remedies are attracting growing interest for their ingenuity. Far from clichés, these ancient practices reveal a methodical approach to health. Medieval manuscripts unveil surprisingly modern ...
For centuries, the University of Heidelberg, Germany, has housed hundreds of medieval medical texts, but their contents--the conditions that were described, the prescriptions that were advised--have ...
Quaderni storici, NUOVA SERIE, Vol. 46, No. 136 (1), Normale/patologico, sano/malato dal medioevo al contemporaneo (APRILE 2011), pp. 13-45 (33 pages) This article examines the efforts of medieval ...
Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...
The Medieval Period, commonly known as The Middle Ages spanned 1,000 years, from the 5th to the 15th century (476 AD to 1453 AD). It is the period in European history which started at the end of ...
Nothing calls to mind nonsensical treatments and bizarre religious healing rituals as easily as the notion of Dark Age medicine. The “Saturday Night Live” sketch “Medieval Barber Theodoric of York” ...
Meg Leja does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...